Validity of Models for Predicting <i>BRCA1</i> and <i>BRCA2</i> Mutations
Annals of Internal MedicinePublished 2 October 2007
Giovanni Parmigiani, Sining Chen, Edwin S. Iversen, Tara M. Friebel, Dianne M. Finkelstein, Hoda Anton-Culver
Citations124
SJR quartileQ1
SJR score3.38
SNIP3.27
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The main goal was to measure how well these models discriminated between mutation carriers and noncarriers, which raises concerns about whether some models are more accurate than others and calls for a careful independent comparative evaluation of the predictive performance of existing models.
Abstract
All models identify women who probably carry a deleterious mutation of BRCA1 or BRCA2 with adequate discrimination to support individualized genetic counseling, although discrimination varies across models and populations.
Keywords
Biochemistry, Genetics and Molecular Biology
The American Journal of Human GeneticsAverage Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
3,685 Citations2003Antonis C. Antoniou, Paul D.P. Pharoah +31 more
Risks in carriers were higher when based on index breast cancer cases diagnosed at <35 years of age and for variation in risk by mutation position for both genes, and some evidence for a reduction in risk in women from earlier birth cohorts is found.
JAMAEvaluating the Yield of Medical Tests
3,442 Citations1982Frank E. Harrell
The treadmill exercise test is shown to provide surprisingly little prognostic information beyond that obtained from basic clinical measurements.
The American Journal of Human GeneticsGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
3,047 Citations1998Deborah Ford, Douglas F. Easton +36 more
The lifetime risk of breast cancer appears similar to the risk in BRCA1 carriers, but there was some suggestion of a lower risk in bRCA2 carriers <50 years of age.
New England Journal of MedicineThe Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews
2,262 Citations1997Jeffery P. Struewing, Patricia Hartge +7 more
The risks of breast cancer may be overestimated, but they fall well below previous estimates based on subjects from high-risk families.
ScienceBreast and Ovarian Cancer Risks Due to Inherited Mutations in <i>BRCA1</i> and <i>BRCA2</i>
2,238 Citations2003Mary‐Claire King, Joan H. Marks +1 more
Physical exercise and lack of obesity in adolescence were associated with significantly delayed breast cancer onset, and risks appear to be increasing with time.
Human HeredityA General Model for the Genetic Analysis of Pedigree Data
1,580 Citations1971Robert C. Elston, Jason A. Stewart
Assuming random mating and random sampling of pedigrees, the likelihood of a set of pedigree data is developed in terms of the population distribution of the different genotypes.
Statistics in MedicineA breast cancer prediction model incorporating familial and personal risk factors
1,361 Citations2004Jonathan P. Tyrer, Stephen W. Duffy +1 more
JNCI Journal of the National Cancer InstitutePitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification
1,016 Citations2003Richard Simon, Michael D. Radmacher +2 more
CancerAutosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
944 Citations1994Elizabeth B. Claus, Neil Risch +1 more
A large number of women with a family history of breast cancer face the task of providing appropriate screening schedules for their patients, and one group for whom this is particularly important are those Women with aFamily history of Breast cancer.
PubMedGenetic analysis of breast cancer in the cancer and steroid hormone study.
916 Citations1991Elizabeth B. Claus, Neil Risch +1 more
Segregation analysis and goodness-of-fit tests of genetic models provide evidence for the existence of a rare autosomal dominant allele (q = .0033) leading to increased susceptibility to breast cancer.
Journal of Clinical OncologyClinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
826 Citations2002Thomas Frank
Specific features of personal and family history can be used to assess the likelihood of identifying a mutation in BRCA1 or BRCa2 in individuals tested in a clinical setting.
The American Journal of Human GeneticsDetermining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
760 Citations1998Giovanni Parmigiani, Donald A. Berry +1 more
A model for evaluating the probabilities that a woman is a carrier of a mutation of BRCA1 and BRCa2, on the basis of her family history of breast and ovarian cancer in first- and second-degree relatives is developed.
Journal of Clinical OncologyAmerican Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility
754 Citations2003
The American Society of Clinical Oncology reaffirms its commitment to integrating cancer risk assessment and management, including molecular analysis of cancer predisposition genes, into the practice of oncology and preventive medicine.
New England Journal of Medicine<i>BRCA1</i>Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
681 Citations1997Fergus J. Couch, Michelle L. DeShano +11 more
The results suggest that even in a referral clinic specializing in screening women from high-risk families, the majority of tests for BRCA1 mutations will be negative and therefore uninformative.
Journal of Clinical OncologyClinical Characteristics of Individuals With Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>: Analysis of 10,000 Individuals
558 Citations2002Thomas S. Frank, Amie M. Deffenbaugh +9 more
Journal of Clinical OncologyBRCAPRO Validation, Sensitivity of Genetic Testing of <i>BRCA1/BRCA2</i>, and Prevalence of Other Breast Cancer Susceptibility Genes
506 Citations2002Donald A. Berry, Edwin S. Iversen +11 more
BRCAPRO is an accurate counseling tool for determining the probability of carrying mutations of BRCA1 and BRCa2, and is highly sensitive, missing an estimated 15% of mutations.
British Journal of CancerThe BOADICEA model of genetic susceptibility to breast and ovarian cancer
477 Citations2004Antonis C. Antoniou, Paul D.P. Pharoah +2 more
This model provides a rational basis for risk assessment in individuals with a FH of breast or ovarian cancer and is closer to the observed values than those obtained using the Claus model and BRCAPRO.
Journal of Clinical OncologySequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
462 Citations1998T. Frank, Susan Manley +23 more
Analysis of these genes should be considered for women diagnosed with breast cancer who have a high probability of carrying a mutation according to the statistical model developed with these data.
JNCI Journal of the National Cancer InstitutePrevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
394 Citations1999Elizabeth Warner, William D. Foulkes +18 more
Genetic testing may be useful when Jewish women with breast cancer are diagnosed before age 50 years or have a close relative with ovarian or early-onset breast cancer.
JNCI Journal of the National Cancer InstituteProbability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family History
383 Citations1997D. A. Berry, Giovanni Parmigiani +3 more
A mathematic model is developed and applied for calculating the probability that a woman with a family history of breast and/or ovarian cancer carries a mutation of BRCA1, and assumes that all other breast cancer is sporadic.
JAMABRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations
378 Citations1997Donna Shattuck-Eidens
Using logistic regression analysis, this work provides a method for evaluating the probability of a woman's carrying a deleterious BRCA1 mutation for a wide range of cases, which can be an important tool for clinicians as they incorporate genetic susceptibility testing into their medical practice.
American Journal of EpidemiologyAGE AT ONSET AS AN INDICATOR OF FAMILIAL RISK OF BREAST CANCER
370 Citations1990Elizabeth B. Claus, Neil Risch +1 more
No effect of case's menopausal status and bilaterality was found, indicating that in addition to a positive family history, age at onset is the strongest indicator of a possible genetic subtype of breast cancer in these data.
Annals of Internal MedicineGenetic Risk Assessment and <i>BRCA</i> Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force
344 Citations2005Heidi D Nelson, Laurie Hoyt Huffman +2 more
The results of genetic testing could lead to prevention interventions for reducing risk or mortality in mutation carriers, and experts recommend earlier and more frequent cancer screening, chemoprevention, and prophylactic surgery.
Journal of Medical GeneticsA new scoring system for the chances of identifying a <i>BRCA1/2</i> mutation outperforms existing models including BRCAPRO
265 Citations2004D. Gareth Evans, D M Eccles +7 more
The Manchester scoring system had the best trade-off between sensitivity and specificity at 10% prediction for the presence of mutations as shown by its highest C-statistic and was far superior to BRCAPRO.
Journal of Genetic CounselingGenetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors
264 Citations2004Angela Trepanier, Mary Ahrens +19 more
These cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without genetic testing.
JAMABRCA1 Mutations and Breast Cancer in the General Population
250 Citations1998Kathleen E. Malone, Janet R. Daling +4 more
While early-onset disease and a strong breast cancer family history may be useful guidelines for checking BRCA1 status, these findings on women drawn from the general population suggest that it may be difficult to develop BRCa1 mutation screening criteria among women with modest family history profiles.
JAMAGenetic Testing in an Ethnically Diverse Cohort of High-Risk Women
245 Citations2005Rita Nanda, L. Philip Schumm +9 more
Irrespective of ancestry, early age at diagnosis and a family history of breast and ovarian cancer are the most powerful predictors of mutation status and should be used to guide clinical decision making.
The American Journal of Human GeneticsThe Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi Jews
226 Citations1999Patricia Hartge, Jeffery P. Struewing +3 more
In men and in women never given a diagnosis of cancer, family history of breast cancer before age 50 years was the strongest predictor of mutation status, and fewer mutations were found in this community sample than in clinical series studied to date.
Journal of Clinical OncologyImpact of BRCA1/BRCA2 Mutation Testing on Psychologic Distress in a Clinic-Based Sample
218 Citations2002M. D. Schwartz
It is suggested that clinic-based BRCA1/2 testing can lead to psychologic benefits for individuals who receive negative test results, and at 6 months after disclosure, those who receive positive or uninformative test results do not exhibit increased psychologic distress or perceived risk.
Journal of Clinical OncologyApplication of Breast Cancer Risk Prediction Models in Clinical Practice
201 Citations2003Susan M. Domchek, Andrea Eisen +4 more
This work reviews available risk assessment tools and discusses their application, and indicates that optimal counseling may require the use of several models, as well as clinical judgment, to provide the most accurate and useful information to women and their families.
Genetic EpidemiologyRisk models for familial ovarian and breast cancer
187 Citations2000Antonis C. Antoniou, S. Gayther +3 more
BRCA1 and BRCA2 may be sufficient to explain the majority of familial ovarian cancer and that families without mutations can be explained by sensitivity of mutation testing and chance clusters of sporadic cases.
Human GeneticsA comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
173 Citations1999E. Gross, Norbert Arnold +3 more
BioTechniquesHigh-Throughput Methods for Detection of Genetic Variation
159 Citations2001Vessela N. Kristensen, Dimitris Kelefiotis +2 more
The most frequently used techniques and instrumental settings applied in different combinations are described, and other methods that are less broadly used but have interesting potentials are discussed.
JNCI Journal of the National Cancer InstitutePretest Prediction of BRCA1 or BRCA2 Mutation by Risk Counselors and the Computer Model BRCAPRO
153 Citations2002David Euhus, Kristin C. Smith +17 more
Sensitivity for identifying BRCA gene mutation carriers is similar for experienced risk counselors and the computer model, BRCAPRO, at identifying families likely to carry a BRCa gene mutation.
Archives of surgeryEffect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis
148 Citations2003Jeffrey N. Weitzel
Outcomes following genetic cancer risk assessment for women newly diagnosed as having breast cancer who were prospectively enrolled in an institutional review board-approved hereditary cancer registry significantly affected women's treatment decisions.
Journal of Clinical OncologyAttitudes, Knowledge, and Risk Perceptions of Women With Breast and/or Ovarian Cancer Considering Testing for <i>BRCA1</i> and <i>BRCA2</i>
141 Citations1999Leslie G. Bluman, Barbara K. Rimer +6 more
Analysis of baseline knowledge, beliefs, and risk perceptions among a group of 200 women with breast and/or ovarian cancer who participated in a trial designed to improve decision making about genetic testing for BRCA1 and BRCa2 provides insight into the challenges clinicians will face in communicating with patients about cancer genetics.
Human GeneticsA comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
134 Citations1999E. Gross, Norbert Arnold +3 more
It is concluded that DHPLC is a highly potent screening method for genetic analyses that is highly sensitive, efficient and economical and can be automated.
Journal of Clinical OncologyImpact of <i>BRCA1</i>/<i>BRCA2</i> Mutation Testing on Psychologic Distress in a Clinic-Based Sample
120 Citations2002Marc D. Schwartz, Beth N. Peshkin +4 more
Journal of Clinical OncologyOptimal Selection of Individuals for <i>BRCA</i> Mutation Testing: A Comparison of Available Methods
120 Citations2006Paul A. James, Rebecca Doherty +5 more
Formal probabilistic models provide significantly greater accuracy in the selection of families for gene testing than the use of clinical criteria or scoring methods.
Journal of Clinical OncologyQuantitating familial cancer risk: a resource for clinical oncologists.
116 Citations1994Kenneth Offit, Karen Brown
Multidisciplinary cancer genetic counseling is an emerging resource available to physicians who care for families with common adult malignancies and is critically reviewed in the context of cancer genetic counselling.
Clinical GeneticsA preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center
114 Citations2000CA Gilpin, Nancy Carson +1 more
In this population, a family history assessment tool (FHAT) was effective in minimizing both the number of referrals and the likelihood of missing women who were later found to be mutation‐positive.
The Breast JournalUnderstanding Mathematical Models for Breast Cancer Risk Assessment and Counseling
110 Citations2001David Euhus
British Journal of CancerA probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families
108 Citations2001Pia Vahteristo, Hannaleena Eerola +3 more
The probability model should be a useful tool in genetic counselling and focusing the mutation analyses, and thus increasing also the cost-effectiveness of the genetic screening.
Journal of Clinical OncologyAssessing <i>BRCA</i> Carrier Probabilities in Extended Families
96 Citations2006Carlos H. Bárcenas, GM Monawar Hosain +10 more
BOADICEA performed better than the other models in Ashkenazi Jewish (AJ) families, BRCAPRO performed slightly better in non-AJ families, and Myriad II performed comparably well in both groups.
Breast Cancer ResearchBRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
92 Citations2005Antonis C. Antoniou, Francine Durocher +4 more
The BOADICEA model predicts accurately the carrier probabilities in French-Canadian families and may be used for counselling in this population, and was found to discriminate well at the individual level between carriers and noncarriers.
Statistical Applications in Genetics and Molecular BiologyBayesMendel: an R Environment for Mendelian Risk Prediction
90 Citations2004Sining Chen, Wenyi Wang +3 more
European Journal of CancerCharacteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer
80 Citations2000Hoda Anton‐Culver, P Cohen +2 more
The results indicate that, using a conservative approach to targeted genotyping of BRCA1, the frequency of mutations was consistent with those reported using similar methods of population-based case ascertainment.
CancerBreast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma
79 Citations2004Anne‐Renee Hartman, Bruce L. Daniel +9 more
Preliminary results from a screening protocol using high‐quality magnetic resonance imaging, ductal lavage, clinical breast examination, and mammography to identify early malignancy and high‐risk lesions in women at increased genetic risk of breast carcinoma are reported.
Genetic TestingPre-Counseling Education Materials for <i>BRCA</i> Testing: Does Tailoring Make a Difference?
79 Citations2002Celette Sugg Skinner, Joellen M. Schildkraut +8 more
TPMs showed an advantage in increasing knowledge and enhancing accuracy of perceived risk, both of which are critical components of informed decision making.
Journal of Clinical OncologyGermline Mutations in <i>BRCA1 </i> and <i> BRCA2 </i> in Breast-Ovarian Families From a Breast Cancer Risk Evaluation Clinic
78 Citations2001Anne‐Marie Martin, M. Anne Blackwood +9 more
It is suggested that at least half of breast/ovarian families evaluated in a high-risk cancer evaluation clinic may have germline mutations in BRCA1 or BRC2, and whether the remaining families have mutations in noncoding regions in B RCA1, mutations in other, as-yet-unidentified, low-penetrance susceptibility genes, or represent chance clustering remains to be determined.
Human MutationComparison of DNA- and RNA-Based Methods for Detection of TruncatingBRCA1 Mutations
77 Citations2002Irene L. Andrulis, Hoda Anton‐Culver +17 more
The present study focused on the detection of protein‐truncating mutations, those that have been reported most often to be disease‐causing alterations that segregate with cancer in families.
Journal of Clinical Oncology<i>BRCA1</i> and <i>BRCA2</i> Genetic Testing in Hispanic Patients: Mutation Prevalence and Evaluation of the BRCAPRO Risk Assessment Model
69 Citations2007Kristen J. Vogel, Deann P. Atchley +8 more
The BRCAPRO model appears to perform equally well in Hispanics as in whites, and Deleterious BRCA1 and BRCa2 mutations occur at considerable frequency within the Hispanic population.
Epidemiologic ReviewsGenetic Epidemiology of Breast and Ovarian Cancers
55 Citations1997Beth Newman, Robert C. Millikan +1 more
The increased risk of breast and ovarian cancers associated with a family history of these diseases is well established, but the relative contributions of biologic inheritance, cultural practices, shared environmental exposures, and chance co-occurrence of disease to this association are only now emerging.
Journal of Medical GeneticsEvaluation of widely used models for predicting <i>BRCA1</i> and <i>BRCA2</i> mutations
54 Citations2004Fabio Marroni, P Aretini +14 more
The main purpose of this study was to compare the performances of published models in predicting mutation test results in breast and ovarian cancers by assessing the pre-test probability of identifying carriers of mutations.
PubMedScreening for 185delAG in the Ashkenazim.
48 Citations1997C. Sue Richards, Patricia A. Ward +6 more
It is concluded that screening for breast and ovarian cancer susceptibility is most appropriate for individuals with a positive personal or positive family cancer history, and a guideline is proposed for future studies designed to identify individuals who may benefit from genetic testing for inherited breast and Ovarian cancer.
Breast Cancer ResearchLog odds of carrying an Ancestral Mutation in BRCA1 or BRCA2for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
41 Citations2003Carmel Apicella, Lesley Andrews +10 more
A simple algorithm to estimate the probability that an Ashkenazi Jewish woman carries an ancestral mutation, based on multiple predictive factors, might be useful in the clinical and genetic counselling setting.
Journal of the American Statistical AssociationGenetic Susceptibility and Survival: Application to Breast Cancer
24 Citations2000Edwin S. Iversen, Giovanni Parmigiani +2 more
Evidence that survival of nonirradiated mutation carriers is better than that of noncarriers and an analysis assessing the separate effects of the two genes indicates that carriers of either mutation may have an improved prognosis.
Journal of Medical GeneticsPre-test prediction models of <i>BRCA1</i> or <i>BRCA2</i> mutation in breast/ovarian families attending familial cancer clinics
22 Citations2003Miguel de la Hoya, O Díez +8 more
All models tested increased the discrimination power of an experienced risk counsellor, suggesting that their use is valuable in the context of clinical counselling and genetic testing to optimise selection of patients for screening and allowing for more focused management.
European Journal of Human GeneticsImproving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software
21 Citations2005Carlo Capalbo, Enrico Ricevuto +14 more
Analysis of the performances of the IC software and widely used models suggests that the country-customized implementation operated on the Brcapro software generated a more accurate tool for the prediction of BRCA1/2 gene mutation.
Annals of SurgeryTesting for Hereditary Breast and Ovarian Cancer in the Southeastern United States
18 Citations2000Alexander Miron, Joellen M. Schildkraut +9 more
Characterization of mutations and uncharacterized variants in the breast cancer susceptibility genes BRCA1 and BRC a2, as observed in a population of breast cancer patients from the southeastern United States, and a preliminary look at how counseling and testing affected intentions toward prophylactic surgery are provided.
Journal of Clinical EpidemiologyActive recruitment increased enrollment in a hereditary cancer registry
16 Citations2004Tara M. Friebel, Ruth Anne Beutler +4 more
Allocating research staff specifically for recruitment and personal contact with potential participants is effective in achieving increased enrollment into a national hereditary cancer research registry.
Europe PMC (PubMed Central)Acquiring good eating and lifestyle habits.
14 Citations1999Gilles Plourde
